AsclepiX Therapeutics is revolutionizing the treatment of retinal diseases and cancer with a singular focus on the design, development, and delivery of novel peptides with the power to inhibit proven key disease pathways. Their peptide drug candidates tap into the body’s powerful mechanisms of maintaining homeostasis, the fundamental principle of biology to seek and maintain a condition of equilibrium or stability.

Biotechnology

AsclepiX Therapeutics

AsclepiX Therapeutics' headquarters in Jersey City, NJ, United States

Jordan J. Green

Niranjan B. Pandey

Aleksander S. Popel

Jeffrey Heier

Peter A. Campochiaro

Allen Ho

David S. Boyer

Sapna Srivastava

Steven M. Altschuler

Josh Barer

This department provides expert guidance and recommendations to support organizational decisions.

Advisory Services

This department provides strategic direction and oversight for the organization.

Executive Leadership

This department oversees strategic direction and guidance for the organization.

Leadership Management

The Leadership Team at AsclepiX Therapeutics is responsible for setting the strategic vision and direction of the company, guiding innovative research and development initiatives for novel peptide therapies. Comprising multiple Vice Presidents, this team collaborates to align cross-functional efforts, drive scientific advancements, and ensure the successful translation of cutting-edge discoveries into effective treatments for retinal diseases and cancer. Their leadership fosters a culture of innovation while maintaining a strong focus on the health and stability of patients through groundbreaking therapies.

Leadership Team

The Scientific and Clinical Development team at AsclepiX Therapeutics is responsible for driving the research and development of innovative peptide therapies aimed at treating retinal diseases and cancer. This team collaborates on preclinical and clinical trials, ensuring that drug candidates are rigorously tested for efficacy and safety while coordinating with regulatory bodies to navigate the approval process. Their multidisciplinary expertise facilitates the translation of scientific discovery into therapeutic solutions, supporting the company’s mission to improve patient outcomes.

AsclepiX Therapeutics

Org chart

Board & advisors

Teams

Advisory Services

Executive Leadership

Leadership Management

Leadership Team

Scientific and Clinical Development

Offices

AsclepiX Therapeutics

Org chart

Board & advisors

Teams

Advisory Services

Executive Leadership

Leadership Management

Leadership Team

Scientific and Clinical Development

Offices

Related companies